Login

Consolidated balance sheets

In millions of USD, except per-share amounts
Q1 FY2024
As of Mar 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q3 FY2021
As of Sep 30, 2021
Q2 FY2021
As of Jun 30, 2021
Q1 FY2021
As of Mar 31, 2021
Q4 FY2020
As of Dec 31, 2020
Q3 FY2020
As of Sep 30, 2020
Q2 FY2020
As of Jun 30, 2020
Q1 FY2020
As of Mar 31, 2020
Q4 FY2019
As of Dec 31, 2019
Q3 FY2019
As of Sep 30, 2019
Q2 FY2019
As of Jun 30, 2019
ASSETS
Current Assets
Cash
Accounts receivable
Inventory, Net
Prepaid expenses
Related party deposits
Other current assets
Current assets of discontinued operations
Total current assets
Property, plant and equipment, net
Finance lease assets
Total liability
Security deposit
Non-current assets of discontinued operations
Total assets
LIABILITIES, CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ DEFICIT
Current Liabilities:
Accounts payable
Accounts payable - related parties
Accrued wages
Accrued expenses
Accrued interest
Convertible notes payable in default
Convertible notes payable, net of discount
Current finance lease liabilities
Current finance lease liabilities - related party
Current operating lease liabilities
Deferred revenue
Derivative liabilities
Loans payable
Related party liabilities
Current liabilities of discontinued operations
Related party liabilities, net of discount
Total Current liabilities
Non-current finance lease liabilities
Non-current finance lease liabilities - related party
Non-current note payable
Non-current operating lease liabilities
Non-current liabilities of discontinued operations
Non-current related party note payable
Total liabilities
Series A convertible preferred stock: 10,100,000 shares authorized, par value $0.0001 61,225 shares issued and outstanding at March 31, 2024 57,749 shares issued and outstanding at December 31, 2023
Series A Preferred Stock
Total series A convertible preferred stock: 10,100,000 shares authorized, par value $0.0001 61,225 shares issued and outstanding at March 31, 2024 57,749 shares issued and outstanding at December 31, 2023
Convertible preferred stock payable
Convertible preferred stock receivable
Stockholders’ deficit:
Common stock: 100,000,000,000 shares authorized, par value $0.0001 9,469,083,427 shares issued and outstanding at March 31, 2024 9,469,083,427 shares issued and outstanding at December 31, 2023
Additional paid in capital
Accumulated deficit
Series A Preferred Stock
Total stockholders’ deficit
Total liabilities and stockholders’ deficit

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support